|
SYNJ1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.1631995366912E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.9592000001274E-08 |
| Normal-vs-Stage2 |
5.64859999999667E-05 |
| Normal-vs-Stage3 |
3.42129657937562E-11 |
| Normal-vs-Stage4 |
1.72110004026393E-09 |
| Stage1-vs-Stage2 |
8.535600E-01 |
| Stage1-vs-Stage3 |
1.634460E-02 |
| Stage1-vs-Stage4 |
3.191600E-02 |
| Stage2-vs-Stage3 |
5.843700E-02 |
| Stage2-vs-Stage4 |
4.884300E-02 |
| Stage3-vs-Stage4 |
7.425200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.61881619220594E-12 |
| Normal-vs-AfricanAmerican |
3.643500E-04 |
| Normal-vs-Asian |
1.376770E-03 |
| Caucasian-vs-AfricanAmerican |
4.115800E-01 |
| Caucasian-vs-Asian |
1.783560E-02 |
| AfricanAmerican-vs-Asian |
4.219200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.76379999073629E-09 |
| Normal-vs-Female |
4.19160040010524E-10 |
| Male-vs-Female |
8.256800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.01289999998588E-06 |
| Normal-vs-Age(41-60Yrs) |
2.87439960722224E-10 |
| Normal-vs-Age(61-80Yrs) |
9.10279962518246E-10 |
| Normal-vs-Age(81-100Yrs) |
4.561400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.236780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.313640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.460200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.891000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.513600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.419000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.244200E-03 |
| Classical-VS-Follicular |
1.025840E-01 |
| Classical-VS-Other |
8.491000E-01 |
| Classical-VS-Normal |
5.05450015175768E-10 |
| Tall-VS-Follicular |
5.010700E-04 |
| Tall-VS-Other |
9.615500E-02 |
| Tall-VS-Normal |
2.37640018774243E-10 |
| Follicular-VS-Other |
7.140800E-01 |
| Follicular-VS-Normal |
4.632300E-04 |
| Other-VS-Normal |
2.953800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.44290001958103E-09 |
| Normal-vs-N1 |
1.35729999461986E-08 |
| N0-vs-N1 |
1.926970E-01 |
|
|
